USFDA Flags One Observation at Cipla Plant

  Published 9 months ago

Cipla received one Form 483 observation after a USFDA cGMP inspection held from 26–30 May 2025.

  • Classification was officially communicated to Cipla via email on 4 August 2025 by the USFDA.
  • Cipla assured full cooperation and plans to address the observation comprehensively within the given timeline.
  • The company remains committed to compliance while focusing on growth in key global and emerging markets.

You might like these

Redington Elevates Apple's Distribution

RITES Bags ₹46.82 Cr Turnkey Project

RBI Drafts Novation Rules for OTC

JM Financial Rates Kalyan “Buy”

Anupam Rasayan FY26 Q2 Surge

Amazon & bolttech Boost CX with Generative AI

Tejas Networks Soars on ₹1525 Crore BSNL 4G Order

News that matters the most ⚡